| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |